Hisashi Urushihara Selected Research

Hisashi Urushihara Research Topics

Disease

4	Human Influenza (Influenza) 01/2022 - 01/2011
3	Pain (Aches) 12/2014 - 06/2007
2	Infections 01/2022 - 01/2014
2	Hemorrhage 01/2022 - 01/2019
2	Stevens-Johnson Syndrome (Lyell's Syndrome) 07/2021 - 01/2019
2	Stroke (Strokes) 01/2019 - 09/2009
2	Rheumatoid Arthritis 05/2015 - 07/2014
2	Osteoporosis 12/2014 - 09/2009
2	Parkinson Disease (Parkinson's Disease) 01/2014 - 01/2011
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2021
1	Chronic Renal Insufficiency 10/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Embolism (Embolus) 01/2019
1	Frailty 01/2019
1	Atrial Fibrillation 01/2019
1	Type 2 Diabetes Mellitus (MODY) 12/2018
1	Respiratory Tract Diseases (Respiratory Tract Disease) 11/2018
1	Pneumonia (Pneumonitis) 11/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2015
1	Vomiting 03/2015
1	Gastroenteritis 03/2015
1	Bronchitis 04/2014
1	Diarrhea 04/2014
1	Eczema 04/2014
1	Hepatitis 01/2014
1	Diabetes Mellitus 05/2013
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2013
1	Hypertension (High Blood Pressure) 05/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2013
1	Drug-Related Side Effects and Adverse Reactions 01/2013
1	Cough 01/2013
1	Postmenopausal Osteoporosis 11/2012
1	Aneuploidy (Aneuploid) 01/2012
1	Chromosomal Instability (Chromosome Stability) 01/2012
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2012

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 01/2019 - 01/2014
3	Raloxifene Hydrochloride (Evista)FDA Link 12/2014 - 09/2009
2	Oseltamivir (Tamiflu)FDA Link 01/2022 - 01/2011
2	ORALIT (ORS)IBA 07/2019 - 11/2018
2	Dopamine Agonists (Dopamine Agonist)IBA 01/2014 - 01/2011
1	baloxavirIBA 01/2022
1	Zanamivir (Relenza)FDA Link 01/2022
1	peramivirIBA 01/2022
1	laninamivirIBA 01/2022
1	Anticonvulsants (Antiepileptic Drugs)IBA 07/2021
1	thiamine triphosphorate (TTP)IBA 01/2021
1	Docetaxel (Taxotere)FDA Link 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	AnticoagulantsIBA 01/2019
1	Warfarin (Coumadin)FDA LinkGeneric 01/2019
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2019
1	Dabigatran FDA Link 01/2019
1	Hypnotics and Sedatives (Sedatives)IBA 01/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2018
1	VaccinesIBA 11/2018
1	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2018
1	ErbB Receptors (EGF Receptor)IBA 10/2015
1	Gefitinib (Iressa)FDA Link 10/2015
1	Antirheumatic Agents (DMARD)IBA 05/2015
1	AntiemeticsIBA 03/2015
1	Domperidone (Domperidon)IBA 03/2015
1	Investigational DrugsIBA 07/2014
1	tocilizumab (atlizumab)FDA Link 07/2014
1	Palivizumab FDA Link 04/2014
1	Levodopa (L Dopa)FDA LinkGeneric 01/2014
1	Fibrinogen (Factor I)FDA Link 01/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2013
1	Pravastatin (Pravachol)FDA LinkGeneric 05/2013
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2013
1	Angiotensin Receptor AntagonistsIBA 01/2013
1	Oxygen (Dioxygen)IBA 01/2012
1	Pergolide (Permax)FDA Link 01/2011
1	Cabergoline FDA LinkGeneric 01/2011
1	Insulin-Like Growth Factor I (IGF-1)IBA 06/2007

Therapy/Procedure

4	Therapeutics 01/2022 - 05/2013
2	Drug Therapy (Chemotherapy) 01/2021 - 05/2013
1	Renal Replacement Therapy (Therapies, Renal Replacement) 10/2021
1	Kidney Transplantation 10/2021
1	Castration 01/2021
1	Polypharmacy 01/2019
1	Fluid Therapy (Oral Rehydration Therapy) 03/2015
1	Activities of Daily Living (ADL) 12/2014